• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by NovaBay Pharmaceuticals, Inc.

< Previous 1 2 3 Next >
NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
March 07, 2025
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
January 23, 2025
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
December 09, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
November 15, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
November 07, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
November 06, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
October 29, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
September 20, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 13, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
August 01, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
July 30, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
July 29, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
July 26, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day
July 16, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
July 11, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
July 01, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers EYEN NBY
NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions
June 28, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American
June 07, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates
May 29, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms
May 13, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
May 09, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
May 07, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
May 03, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
April 22, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
April 19, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
April 17, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
March 26, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
March 25, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
March 14, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
January 30, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
< Previous 1 2 3 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap